vignesh85

vignesh85 | Joined since 2020-04-09

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

13

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
13
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2021-07-21 12:07 | Report Abuse

Trust in vaccination rate. The next month, many will be receiving 2nd dose already. Let the foreign fund sell all they want now. we collect and make them buy higher from us in the next month. stock market is a cycle.

Stock

2021-07-18 17:09 | Report Abuse

operation surge capacity will cause surge in the market soon

Stock

2021-07-13 21:19 | Report Abuse

At current level, it is a buy..RSI at oversold region already.

Stock

2020-06-05 15:45 | Report Abuse

government to go for digitalisation and incorporate more services into e-government services

Stock

2020-06-05 15:40 | Report Abuse

tax break for companies who conducts covid test! Who will be the beneficiary?

Stock

2020-06-04 13:08 | Report Abuse

Okay we respect each others viewpoint. But to the naysayers, i will see you at the end of the month :)

Stock

2020-06-03 23:32 | Report Abuse

Diversification is the way forward for companies like MYEG. They need to evolve so that they do not overly dependent on one or two contracts for sustenance. Perkeso's scheme is there up for grabs and MYEG is making it convenient for the employers to screen their workforce. I think it will just increase their income stream.

Stock

2020-06-03 20:05 | Report Abuse

With Myeg Medical Services, they can now tap into Perkeso's Prihatin Program where the government subsidizes RM150 per employee for Covid testing. All they need to do now is to acquire a clinic which has Perkeso panelship and provide on site screening.

Stock

2020-06-02 15:46 | Report Abuse

even if it closes at 1.32 today, it forms a nice green hammer resting at EMA20. RSI pointing upwards. Poised for a uptrend rebound.

Stock

2020-05-31 23:00 | Report Abuse

actually it will benefit Myeg as it offers convenience to employers to screen the employee. Based on their previous media release, they have clarified that they are not directly working with Perkeso. They are facilitating the screening by engaging clinic that is in Perkeso panel to do onsite screening.
With the government paying subsidy of RM150, more employers (in the subsidy program) will come forward to get their workers screened. Perkeso will pay the subsidy as long it is done by a doctor/clinic approved by them. Onsite screening is obviously more convenient for the employers.

Stock

2020-05-27 19:38 | Report Abuse

Once a manufacturer/shipper is placed on Level 2 detention, FDA may need greater assurance that the medical gloves are not adulterated before removing the manufacturer/shipper from detention without physical examination status. For example, 10 consecutive non-violative shipments, analyzed by an independent testing laboratory, may be considered adequate evidence that the manufacturer/shipper is shipping medical gloves to the U.S. which are not adulterated. Other types of evidence to remove the appearance of a violation will be evaluated by CDRH on a case-by-case basis


No such thing as containers a being sent back. simply creating false news.

Stock

2020-05-18 20:26 | Report Abuse

KYY already mentioned that Supermax and Comfort is the best stock to buy for gloves. Lower PE and better EPS growth prospects.

Stock

2020-05-16 12:44 | Report Abuse

Look at it rationally. apart from impairment (which is one off and does not involve cash), the company manage to report profit on its operating profit. How many companies could report profit during this pandemic? a profit is a profit.
The share price came down from a high of 0.9 cents to 0.3 cents factoring this weak quarter. the stock price will always reflect what is ahead. Next quarter if the company can even report RM1m net profit (which they should easily be able to do), just ponder what the growth numbers will look like. I believe the management is putting this trajectory when they decided to factor the impairment. Future growth numbers.